QV Investors Inc. raised its position in Centene Corporation (NYSE:CNC – Free Report) by 30.5% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 471,952 shares of the company’s stock after acquiring an additional 110,230 shares during the period. Centene makes up about 1.6% of QV Investors Inc.’s holdings, making the stock its 21st largest position. QV Investors Inc.’s holdings in Centene were worth $19,421,000 at the end of the most recent reporting period.
Other institutional investors also recently modified their holdings of the company. Addison Advisors LLC lifted its holdings in shares of Centene by 455.6% in the 3rd quarter. Addison Advisors LLC now owns 739 shares of the company’s stock worth $26,000 after purchasing an additional 606 shares in the last quarter. Mowery & Schoenfeld Wealth Management LLC bought a new stake in Centene during the 3rd quarter valued at $27,000. WPG Advisers LLC raised its holdings in Centene by 44.5% during the third quarter. WPG Advisers LLC now owns 915 shares of the company’s stock worth $33,000 after buying an additional 282 shares during the last quarter. Bogart Wealth LLC lifted its stake in shares of Centene by 11,011.1% in the third quarter. Bogart Wealth LLC now owns 1,000 shares of the company’s stock valued at $36,000 after buying an additional 991 shares in the last quarter. Finally, Ameriflex Group Inc. grew its holdings in shares of Centene by 152.5% during the third quarter. Ameriflex Group Inc. now owns 1,010 shares of the company’s stock valued at $36,000 after buying an additional 610 shares during the last quarter. 93.63% of the stock is owned by institutional investors and hedge funds.
Analyst Ratings Changes
CNC has been the subject of several recent research reports. Deutsche Bank Aktiengesellschaft boosted their target price on shares of Centene from $32.00 to $39.00 and gave the stock a “hold” rating in a research report on Tuesday, February 10th. Wall Street Zen downgraded Centene from a “buy” rating to a “hold” rating in a research note on Sunday, February 15th. TD Cowen increased their price objective on Centene from $34.00 to $38.00 and gave the stock a “hold” rating in a research note on Wednesday, February 11th. JPMorgan Chase & Co. dropped their target price on Centene from $45.00 to $41.00 and set a “neutral” rating on the stock in a report on Thursday, March 19th. Finally, Argus upgraded Centene to a “hold” rating in a report on Monday, February 9th. Three research analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $41.81.
Centene Stock Down 0.1%
CNC opened at $35.09 on Friday. Centene Corporation has a fifty-two week low of $25.08 and a fifty-two week high of $66.03. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.10 and a quick ratio of 1.10. The company’s 50-day moving average is $39.20 and its 200 day moving average is $38.76. The firm has a market capitalization of $17.26 billion, a P/E ratio of -2.58, a PEG ratio of 0.78 and a beta of 0.59.
Centene (NYSE:CNC – Get Free Report) last posted its quarterly earnings data on Friday, February 6th. The company reported ($1.19) EPS for the quarter, beating the consensus estimate of ($1.22) by $0.03. Centene had a negative net margin of 3.43% and a positive return on equity of 4.25%. The firm had revenue of $49.73 billion during the quarter, compared to analyst estimates of $48.41 billion. During the same quarter last year, the business posted $0.80 EPS. The company’s revenue for the quarter was up 21.9% on a year-over-year basis. Centene has set its FY 2026 guidance at 3.000-3.000 EPS. Research analysts expect that Centene Corporation will post 6.86 earnings per share for the current fiscal year.
Centene Company Profile
Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.
Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.
Recommended Stories
Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Corporation (NYSE:CNC – Free Report).
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.
